Journal article

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

Ashray Gunjur, Oliver Klein, Damien Kee, Jonathan Cebon

Journal for ImmunoTherapy of Cancer | BMC | Published : 2019

DOI: 10.1186/s40425-019-0713-y

University of Melbourne Researchers

Grants

Funding Acknowledgements

The cost of open-access publication was funded by Ludwig Cancer Research (the Olivia Newton-John Cancer Research Institute).

Keywords

Immune Checkpoint Inhibitor
Thyroiditis
Science & Technology
Pd1 Inhibitor
Hypothyroidism
Diabetes Mellitus
Pembrolizumab
Hypoadrenalism
Inhibitor
Oncology
Therapy
Patient
Life Sciences & Biomedicine
Immunology
Poly-Endocrinopathy